50% of Mandaue students immunized in vaccine drive

Mary Rose Sagarino 10/17/2024

MANDAUE CITY, Philippines — The Mandaue City Health Department (MCHD) was able to immunize about 50 percent of the targeted students against measles, rubella, tetanus, diphtheria, and human papillomavirus (HPV). MCHD started its vaccination campaign on October…

The Sinovac conundrum

Gideon Lasco - @inquirerdotnet 03/05/2021

To be or not to be vaccinated with Sinovac: That is the question health care workers all over the country are facing today. On a personal level, most health care workers believe in vaccination and seek protection…

Rumors and fear dog Philippine plan for coronavirus vaccine drive

Reuters 01/28/2021

MANILA, Philippines — In the Philippines, a country of 108 million, memories of a dengue vaccine that has been banned locally are putting people off the idea of coronavirus immunization even before the campaign begins. “Many kids…

The miracle of vaccines

Peter Wallace - @inquirerdotnet 09/24/2020

The first vaccine was developed in 1796 by Edward Jenner, who used cowpox material to develop immunity to smallpox. According to historyofvaccines.org, the next major breakthrough occurred in 1885, almost 100 years later: the development of the…

Robredo: ‘Politicized’ Dengvaxia caused fear of vaccines

Neil Arwin Mercado - Inquirer.net 09/29/2019

MANILA, Philippines — Vice President Leni Robredo on Sunday attributed the fear of many parents against vaccines on the “politicized” issue of the anti-dengue vaccine Dengvaxia. Robredo made the remark amid the resurgence in the country of…

Cebu PHO falls short of polio vaccination target

Rosalie Abatayo 09/23/2019

CEBU CITY, Philippines — While Cebu province has remained polio-free, the Cebu Provincial Health Office (PHO) is asking parents to have their children vaccinated to avoid the dreaded disease. Dr. Christina Gianggo, PHO chief, said that Cebuanos should…

Duque: Vaccine scare, ‘anti-vaxxers’ among causes of polio resurgence

Katrina Hallare - Inquirer.net 09/21/2019

MANILA, Philippines — One of the reasons for the re-emergence of polio in the country was due to the vaccine scare caused by the controversy on the use of dengue serum Dengvaxia, Health Secretary Francisco Duque III…

As dengue rises, Palace open to Dengvaxia use

08/01/2019

MANILA, Philippines — Filipinos may not have seen the last of the controversial Dengvaxia vaccine yet. The Duterte administration is still open to allowing the use of the dengue vaccine again if experts agree to recommend it…

Rise in measles cases prompts increase in parents availing of free MMRV vaccinations in Cebu City

Delta Dyrecka Letigio 02/08/2019

  CEBU CITY, Philippines — The announcement of the rise in measles cases in Cebu City has prompted parents to avail of the free vaccination for this disease. Dr. Alma Corpin said that many parents had become…

Delos Santos attributes rise in measles cases to Dengvaxia scare

Delta Dyrecka Comendador Letigio 02/08/2019

Cebu City, Philippines – Cebu City Councilor Mary Anne Delos Santos, deputy mayor on health, attributes the increase of measles cases to the scare of the dengvaxia vaccine. Delos Santos said that the fear of vaccination became…

Hoax: Dengvaxia vaccine sells cheaper in India

Inquirer.net 11/08/2018

A social media post claiming that anti-dengue vaccine Dengvaxia was being sold in India for a cheaper price than in the Philippines is fake. This was the result of a verification and fact-checking made by Agence France…

Lawyers, doctors preparing cases vs Duque over Dengvaxia mess

Inquirer.net 08/30/2018

PUBLIC Attorneys’ Office (PAO) forensics chief Dr. Erwin Erfe revealed yesterday that lawyers and doctors are preparing cases against Health Secretary Francisco Duque III to revoke his license as a doctor in connection with the alleged deaths…

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.